USPTO Patent Application for Tavapadon in Parkinson's Disease Treatment
Summary
The USPTO has published a patent application (US20260083740A1) detailing methods for treating Parkinson's Disease using escalating doses of tavapadon. The application was filed on September 23, 2025, by inventor Sridhar Duvvuri.
What changed
This document is a USPTO patent application (US20260083740A1) for a method of treating Parkinson's Disease by administering escalating doses of tavapadon. The application was filed on September 23, 2025, and lists Sridhar Duvvuri as the inventor. The CPC classifications indicate relevance to pharmaceutical compositions and treatments for nervous system disorders.
As this is a patent application, it does not impose immediate regulatory obligations on pharmaceutical companies or healthcare providers. However, it signifies potential future intellectual property and market exclusivity for tavapadon in Parkinson's Disease treatment, which may influence R&D strategies and competitive landscapes.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
USE OF TAVAPADON IN TREATING PARKINSON'S DISEASE
Application US20260083740A1 Kind: A1 Mar 26, 2026
Inventors
Sridhar Duvvuri
Abstract
The present disclosure relates to methods for treating a patient diagnosed with Parkinson's Disease (PD) by administering an escalating dose of tavapadon and monitoring efficacy of PD treatment.
CPC Classifications
A61K 31/513 A61K 31/198 A61K 45/06 A61P 25/16
Filing Date
2025-09-23
Application No.
19337808
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.